
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Architect Dan Chapel reveals what veterinarians regret the most about the first hospitals they build.
The problem never seems to be filling the space, but finding the space to fill, says Veterinary Economics Editorial Advisory Board member Dan Chapel, AIA, owner of Chapel Associates Architects in Little Rock, Ark.





